About Emerivo
We are defining a new category: AI Discovery & Commercial Visibility.
Emerivo is not an AI company, an SEO agency, or a digital marketing firm. We are a specialist commercial visibility partner for pharmaceutical manufacturing and research organisations — built around one belief: AI has become the first stage of supplier discovery, and it is currently invisible to most companies.
Our position
AI is the mechanism. Commercial growth is the outcome.
We don't position ourselves around AI technology because AI is not the point. The point is that buyers — procurement leads, sourcing teams, commercial and BD heads — are changing how they find manufacturing and research partners, and that shift has direct commercial consequences for suppliers who are hard for AI to understand.
Everything we build, from our methodology to our published research, exists to answer one question on behalf of our clients: when a buyer asks AI to recommend a partner like you, does AI confidently include you — and describe you correctly?
Why a new category
Not AI consulting. Not SEO. Not marketing.
Pharmaceutical partner discovery is highly specialised, highly regulated, and easy for generalist agencies to get wrong. We built Emerivo specifically to close the gap between how pharmaceutical manufacturing and research organisations actually operate, and how clearly AI models are currently able to understand that.
That requires proprietary methodology, original research, and hands-on execution — not a generic playbook borrowed from another industry.
Knowledge-first, by design
Our research and methodology are published — not locked behind a sales call
We treat original research, our AI Discovery Reports™, and our Knowledge Hub as strategic assets in their own right — proof of the methodology, available before any commercial conversation begins. Services are the practical application of that knowledge, not a substitute for it.
Why Emerivo
Three commitments that shape how we work
Specialised for Pharmaceutical Organisations
We work exclusively with TPMs, CMOs, CDMOs and CROs. Pharmaceutical manufacturing and research is a highly specific domain — regulatory nuance, certifications and buyer language all matter, and generalist agencies routinely miss them.
We Execute
We do not hand over a slide deck and disappear. Our team restructures websites, rewrites content and implements the changes required to improve AI understanding — from strategy through to execution.
Continuous Monitoring
AI models are updated constantly, and buyer questions evolve. We continuously re-test your visibility and keep refining your positioning, rather than treating AI discovery as a one-time project.
Who we serve
Third-Party Manufacturers, CMOs, CDMOs and CROs — exclusively
We do not serve buyers, and we do not serve every industry. That focus is deliberate: it is what allows us to build genuine domain expertise rather than generalist knowledge spread thin across unrelated sectors.
See whether AI recommends your company when buyers search for a partner
Request an AI Discovery Audit™ and get a clear, evidence-based view of where you stand today.